Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tatjana M. Odrljin
Observed names:
T. M. Odrljin,
T. Odrljin,
T.M. Odrljin,
TM Odrljin,
Tatjana Odrljin
Institution:
Boston Pharmaceuticals (United States)
Observed institutions:
Nathan Kline Institute for Psychiatric Research,
University of Utah,
Huntsman Cancer Institute,
University of Rochester Medicine,
Novartis (United States),
Alexion Pharmaceuticals (United States),
Boston Pharmaceuticals (United States),
University of Rochester
show all 8
OpenAlex ID:
A5113587863
Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin
1998
·
Abha Sahni
, Tatjana Odrljin
, et al.
·
Journal of Biological Chemistry
·
243
Asfotase alfa therapy for children with hypophosphatasia
2016
·
Michael P. Whyte
, Katherine L. Madson
, et al.
·
JCI Insight
·
182
PDF
The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix
2002
·
Marian Pereira
, Brain J. Rybarczyk
, et al.
·
Journal of Cell Science
·
130
Calpain Mediates Calcium-Induced Activation of the Erk1,2 MAPK Pathway and Cytoskeletal Phosphorylation in Neurons
2004
·
Veeranna
, Takahide Kaji
, et al.
·
American Journal Of Pathology
·
127
PDF
Binding of Tissue-Plasminogen Activator to Fibrin: Effect of Ultrasound
1998
·
Farhan Siddiqi
, Tatjana M. Odrljin
, et al.
·
Blood
·
122
PDF
Burden of disease in adult patients with hypophosphatasia: Results from two patient-reported surveys
2016
·
Thomas J. Weber
, Eileen K. Sawyer
, et al.
·
Metabolism
·
107
Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain
1996
·
TM Odrljin
, JR Shainoff
, et al.
·
Blood
·
73
Heparin-Binding Domain of Fibrin Mediates Its Binding to Endothelial Cells
1996
·
Tatjana M. Odrljin
, Charles W. Francis
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
59
PDF
Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with phenotypic metabolic dysfunction-associated steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
2025
·
Rohit Loomba
, Kris V Kowdley
, et al.
·
The Lancet. Gastroenterology & hepatology
·
52
Antibody Persistence and Response to a Booster Dose of a Quadrivalent Conjugate Vaccine for Meningococcal Disease in Adolescents
2012
·
Robert M. Jacobson
, Lisa A. Jackson
, et al.
·
The Pediatric Infectious Disease Journal
·
49
Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents
2014
·
Roger Baxter
, Keith Reisinger
, et al.
·
The Journal of Pediatrics
·
47
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers
2012
·
Nicola P. Klein
, Julie Shepard
, et al.
·
Vaccine
·
36
Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
2014
·
Miguel Tregnaghi
, Pio Lopez
, et al.
·
International Journal of Infectious Diseases
·
35
Antibody Persistence After Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents
2014
·
Roger Baxter
, Keith Reisinger
, et al.
·
The Pediatric Infectious Disease Journal
·
34
Integrin α v β 3-Mediated Endocytosis of Immobilized Fibrinogen by A549 Lung Alveolar Epithelial Cells
2001
·
Tatjana M. Odrljin
, Constantine G. Haidaris
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
31
Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age
2013
·
Terry M Nolan
, Michael D Nissen
, et al.
·
Human Vaccines & Immunotherapeutics
·
30
PDF
Calcium modulates plasmin cleavage of the fibrinogen D fragment γ chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the γ chain
1996
·
Tatjana M. Odrljin
, Brian J. Rybarczyk
, et al.
·
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
·
28
PDF
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants
2014
·
Arturo Abdelnour
, Peter E. Silas
, et al.
·
Vaccine
·
25
Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults
2014
·
Hoan Jong Lee
, Moon-Hyun Chung
, et al.
·
International Journal of Infectious Diseases
·
24
PDF
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
2026
·
Mazen Noureddin
, Kris V Kowdley
, et al.
·
The Lancet
·
20
The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age
2013
·
Geraldine Blanchard-Rohner
, Matthew D. Snape
, et al.
·
Vaccine
·
19
Immunochemical Characterisation of a Murine Monoclonal Anti-Idiotypic Antibody
1992
·
Lj. Dimitrijević
, M. Radulović
, et al.
·
Journal of Immunoassay
·
13
Hypophosphatasia: a retrospective natural history study of the severe perinatal and infantile forms
2014
·
Michael Whyte
, Edward Leung
, et al.
·
Bone Abstracts
·
11
723: Once-monthly Efimosfermin Alfa (bos-580) in Metabolic Dysfunction-associated Steatohepatitis With F2/f3 Fibrosis: Results From a 24 Week, Randomized, Double-blind, Placebo-controlled, Phase 2 Trial
2025
·
Mazen Noureddin
, Kris V. Kowdley
, et al.
·
Gastroenterology
·
7
PDF
Sustained efficacy and tolerability in infants and young children with life-threatening hypophosphatasia treated with asfotase alfa
2014
·
Michael Whyte
, Jill Simmons
, et al.
·
Bone Abstracts
·
6
Show more works
View as search
Works count:
42
Citation count:
1,538
H-index:
20
I10-index:
23
Year
Topic
Type
